LDOS enters July with analysts cutting targets in unison, the stock down nearly 20% over the past month, and a Q1 earnings print still fresh in investors' minds — the question now is whether the selling is finished or whether more is coming.
The analyst story has been unusually active. Street coverage has turned decisively more cautious, with multiple firms trimming targets in quick succession. Most notably, Citigroup's John Godyn cut his target this week from $178 to $138 while holding a Buy rating — notable because it marks his second target reduction in two months, having already dropped from $232 in May. Bank of America went further on June 17, downgrading outright from Buy to Neutral and slashing its target from $200 to $125. Jefferies also downgraded in early June, from Buy to Hold, with a $140 target. The consensus target has compressed to $168, sitting well above the current price of $102.97 — though that gap reflects the speed of the decline rather than bullish conviction. RBC and Truist remain constructive but both trimmed in May. The bear case rests on contract margin pressure and uncertainty around federal budget priorities; bulls counter that Leidos has a track record of disciplined M&A and that long-term government IT spending remains intact.
Positioning in the lending market is about as relaxed as it gets for a name with this kind of momentum headwind. Borrow availability is extremely loose — over 3,300% of current short interest — meaning there is no friction preventing new short exposure. Cost to borrow is just 0.40%, roughly in line with the prior month despite a small uptick. Short interest itself has actually been falling, down 15.6% on the week and now running at 3.2% of the free float. That compression suggests shorts have been covering into the decline rather than pressing it. The ORTEX short score has also eased, dropping from around 38.7 earlier in June to 35.2 — still in moderate territory, but moving in the less-aggressive direction. Options are similarly unconvincing as a fear signal: the put/call ratio stands at 0.72, marginally below its 20-day average of 0.75 and well within normal range. Positioning overall looks cautious rather than crowded short.
The earnings calendar adds another variable. Leidos reports next on August 4. The most recent print — Q1 on May 5 — was punishing: the stock fell 9.3% on the day and extended to -13.7% by the end of the week. That reaction landed the stock near $135, and it has drifted another 25% lower since. Valuation has repriced accordingly. The P/E ratio has compressed by roughly 1.75 turns over the past 30 days and now sits at 8.2x, while EV/EBITDA is around 6.8x — levels that look cheap against the sector if earnings estimates hold, but which could tighten further if guidance disappoints again.
Peer divergence is worth noting. Close comparable KBR gained 4% on the week and PSN added 6.4%, while BAH fell 5% — broadly mirroring LDOS's trajectory. SAIC managed a 5% recovery. The split performance suggests this is not a sector-wide rotation but a stock-specific repricing tied to Leidos's own contract and guidance story.
With the August 4 earnings date approaching, the focus will be on whether management can stabilise the revenue outlook and arrest further analyst target compression — or whether the Q1 pattern repeats.
See the live data behind this article on ORTEX.
Open LDOS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
